Daniel Mitchell - Director, Arca Biopharma, Inc

As of January 13, 2021


Daniel Mitchell Net Worth

  • Net worth is estimated to be at least $535.71K
  • Owns at least 11,000 units of Arca Biopharma, Inc stock

Daniel Mitchell Trading

  • Largest purchase of shares was 11,000 units , worth over $29.81K on May 3, 2017
  • In total has made about 6 transactions over 6 years
  • Usually trades in February, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Arca Biopharma, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Michael R. Bristow 2020 $286,083 $619,976 $144,000 $11,528 $1,061,587
Michael R. Bristow 2019 $284,328 - - $11,823 $296,151
Thomas A. Keuer 2020 $284,937 $228,412 $98,000 $19,675 $631,024
Thomas A. Keuer 2019 $283,189 - - $20,833 $304,022
Christopher D. Ozeroff 2020 $279,617 $179,467 $84,000 $12,764 $555,848
Christopher D. Ozeroff 2019 $277,901 - - $12,256 $290,157
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/907654/000156459021019817/abio-def14a_20210610.htm

Arca Biopharma, Inc Insider Trading

  • The most recent transaction was 50,000 units bought on November 23, 2021 by Christopher D. Ozeroff worth over $113.21K
  • In the last 12 years, insiders at Arca Biopharma, Inc sold an estimated value of $15.26M and bought an estimated value of $3.82M
  • The most active traders are Michael Bristow, Pres. & Chief Executive Offic,  Christopher D. Ozeroff, S.V.P.,  and Robert Conway, Director
  • Insider trading is most common in February, with the busiest year in 2016

ARCA biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1